Valeant Pharmaceuticals International Chief Executive Joseph Papa took in $62.7 million in pay last year as it navigated the fallout from accounting problems, a near debt default and investigations by Congress.
WSJ.com: US Business, Wall Street Journal: Business
Thu, 03/23/2017 - 6:41am
Valeant Pharmaceuticals International Chief Executive Joseph Papa took in $62.7 million in pay last year as it navigated the fallout from accounting problems, a near debt default and investigations by Congress.